Are healthcare workers immune to rubella?

Human Vaccines and Immunotherapeutics

Volumn 10, Issue 3, 2014, Pages 686-691

  Borras̀, Eva ^a,b,c   Campins, Magda ^d   Esteve, María ^e   Urbiztondo, Luis ^a   Broner, Sonia ^c   Bayas, José María ^f   Costa, Josep ^f   Domińguez, Angela ^b,c  

^a AGÈNCIA DE SALUT PÚBLICA DE BARCELONA   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^d HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^e Hospital Germans Trias   (Spain)

^f HOSPITAL CLÍNIC   (Spain)

Author keywords

Healthcare workers; MMR vaccination; Nosocomial transmission; Rubella; Seroprevalence

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; RUBELLA ANTIBODY; IMMUNOGLOBULIN G; VIRUS ANTIBODY;

ADULT; AGE DISTRIBUTION; ANTIBODY BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; FEMALE; HEALTH CARE PERSONNEL; HEALTH CENTER; HOSPITAL PERSONNEL; HUMAN; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NURSE; PHYSICIAN; PRIMARY MEDICAL CARE; RUBELLA; SEROPREVALENCE; SEX DIFFERENCE; SPAIN; VACCINATION; VIRUS IMMUNITY; BLOOD; EPIDEMIOLOGY; IMMUNOASSAY; IMMUNOLOGY; MIDDLE AGED; QUESTIONNAIRE;

ADULT; ANTIBODIES, VIRAL; BLOOD; FEMALE; HEALTH PERSONNEL; HUMANS; IMMUNOASSAY; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; RUBELLA; SEROEPIDEMIOLOGIC STUDIES; SURVEYS AND QUESTIONNAIRES;

EID: 84898472012     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.27498     Document Type: Article

References (35)

1. Maldonado YA. Rubella Virus. In: Long SS, Pickering LK, Prober CG, eds. Principles and Practice of Pediatric Infectious Diseases. 3rd ed. New York: Churchill Livingstone Elsevier, 2008.
2. Cradock-Watson JE, Ridehalgh MKS, Anderson MJ, Pattison JR, Kangro HO. Fetal infection resulting from maternal rubella after the first trimester of pregnancy. J Hyg (Lond) 1980; 85:381-91; PMID:7462590; http://dx.doi.org/10. 1017/S0022172400063452
3. Miller E, Cradock-Watson JE, Pollock TM. Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet 1982; 2:781-4; PMID:6126663; http://dx.doi.org/10.1016/S0140-6736(82)92677-0
4. World Health Organization. Eliminating measles and rubella and preventing congenital rubella. WHO European Region Strategic Plan 2005-2010. Geneva, 2005.
5. World Health Organization. Controlling rubella and preventing congenital rubella syndrome - global progress, 2009. Wkly Epidemiol Rec 2010; 85:413-8; PMID:20949700
6. World Health Organization. Global measles and rubella. Strategic Plan 2012-2020. Geneva: World Health Organization, 2012.
7. World Health Organization. Rubella Reported Cases. Available at: http://apps.who.int/immunization-monitoring/globalsummary/timeseries/ tsincidencerubella.html. Accesed on November 15, 2013.
8. Domínguez A, Plans P, Costa J, Torner N, Cardenosa N, Batalla J, Plasencia A, Salleras L. Seroprevalence of measles, rubella, and mumps antibodies in Catalonia, Spain: results of a cross-sectional study. Eur J Clin Microbiol Infect Dis 2006; 25:310-7; PMID:16786377; http://dx.doi.org/10.1007/ s10096-006-0133-z
9. Generalitat de Catalunya. L'eliminació de la rubèola a Catalunya per a l'any 2005. Bases científiques i programa. Barcelona 2002. Available online: http://www20.gencat.cat /docs /canalsalut /Home%20Canal%20Salut/Professionals/Temes-de-salut/Vigilancia-epidemiologica/ documents/eliminacio-rubeola.pdf. Accessed December 3, 2013.
10. Lemos C, Ramírez R, Ordobas M, Guibert DH, Sanz JC, García L, Martínez Navarro JF. New features of rubella in Spain: the evidence of an outbreak. Euro Surveill 2004; 9:9-11; PMID:15192263
11. Torner N, Valerio L, Costa J, Parrón I, Dominguez A. Rubella outbreak in young adults of Brazilian origin in a Barcelona suburb, October-December 2005. Euro Surveill 2006; 11:E060223.3; PMID:16804218
12. García L; Red de Vigilancia Epidemiológica de la Comunidad de Madrid (Epidemiological Surveillance Network of the Autonomous Region of Madrid). Outbreak of rubella in the Madrid region, Spain, 2005. Euro Surveill 2005; 10:E050707.2; PMID:16785654
13. Kasper S, Allerberger F, Aberle S, Holzmann H, Redlberger M, Daghofer E, Jakse H, Wassermann-Neuhold M, Feenstra O, Krischka C, et al. Rubella in Austria 2008-2009: no longer a typical childhood disease. Pediatr Infect Dis J 2010; 29:448-52; PMID:20032808; http://dx.doi.org/10.1097/INF.0b013e3181cc3db6
14. Menegolla IA, Bercini MA, Schermann MT, Nunes ZM, Segatto TC, Siqueira MM, Flannery B. Outbreak of rubella after mass vaccination of children and adult women: challenges for rubella elimination strategies. Rev Panam Salud Publica 2011; 29:243-51; PMID:21603769; http://dx.doi.org/10.1590/S1020- 49892011000400005
15. Polk BF, White JA, DeGirolami PC, Modlin JF. An outbreak of rubella among hospital personnel. N Engl J Med 1980; 303:541-5; PMID:7402219; http://dx.doi.org/10.1056/NEJM198009043031001
16. Heseltine PN, Ripper M, Wohlford P. Nosocomial rubella - consequences of an outbreak and efficacy of a mandatory immunization program. Infect Control 1985; 6:371-4; PMID:3850860
17. Nerome Y, Nishi J, Fujiyama R, Takei S, Yoshinaga M, Kawano Y. [An outbreak of rubella among hospital personnel and measures taken against hospital infection - cost-benefits of the measure]. Kansenshogaku Zasshi 2004; 78:967-74; PMID:15628529
18. Skendzel LP. Rubella immunity. Defining the level of protective antibody. Am J Clin Pathol 1996; 106:170-4; PMID:8712168
19. Almuneef MA, Memish ZA, Balkhy HH, Otaibi B, Helmi M. Seroprevalence survey of varicella, measles, rubella, and hepatitis A and B viruses in a multinational healthcare workforce in Saudi Arabia. Infect Control Hosp Epidemiol 2006; 27:1178-83; PMID:17080374; http://dx.doi.org/10.1086/508826
20. Silveira MB, Perez DA, Yamaguti A, Saraiva EZ, Borges MG, de Moraes-Pinto MI. Immunization status of residents in pediatrics at the Federal University of São Paulo, Brazil. Rev Inst Med Trop Sao Paulo 2011; 53:73-6; PMID:21537753
21. Asari S, Deguchi M, Tahara K, Taniike M, Toyokawa M, Nishi I, Watanabe M, Iwatani Y, Makimoto K. Seroprevalence survey of measles, rubella, varicella, and mumps antibodies in health care workers and evaluation of a vaccination program in a tertiary care hospital in Japan. Am J Infect Control 2003; 31:157-62; PMID:12734521; http://dx.doi.org/10.1067/mic.2003.16
22. Campagna M, Bacis M, Belotti L, Biggi N, Carrer P, Cologni L, Gattinis V, Lodi V, Magnavita N, Micheloni G, et al. [Exanthemic diseases (measles, chickenpox, rubella and parotitis). Focus on screening and health surveillance of health workers: results and perspectives of a multicenter working group]. G Ital Med Lav Ergon 2010; 32:298-303; PMID:21061713
23. Kumakura S, Shibata H, Onoda K, Nishimura N, Matsuda C, Hirose M. Seroprevalence survey on measles, mumps, rubella and varicella antibodies in healthcare workers in Japan: sex, age, occupational-related differences and vaccine efficacy. Epidemiol Infect 2014; 142:12-9; PMID:23574767
24. Rajasundari TA, Chandrasekar K, Vijayalakshmi P, Muthukkaruppan V. Immune status of health care personnel & post vaccination analysis of immunity against rubella in an eye hospital. Indian J Med Res 2006; 124:553-8; PMID:17213524
25. Aypak C, Bayram Y, Eren H, Altunsoy A, Berktaş M. Susceptibility to measles, rubella, mumps, and varicella-zoster viruses among healthcare workers. J Nippon Med Sch 2012; 79:453-8; PMID:23291844
26. Vagholkar S, Ng J, Chan RC, Bunker JM, Zwar NA. Healthcare workers and immunity to infectious diseases. Aust N Z J Public Health 2008; 32:367-71; PMID:18782402; http://dx.doi.org/10.1111/j.1753-6405.2008.00257.x
27. Alp E, Cevahir F, Gökahmetoglu S, Demiraslan H, Doganay M. Prevaccination screening of health-care workers for immunity to measles, rubella, mumps, and varicella in a developing country: What do we save? J Infect Public Health 2012; 5:127-32; PMID:22541258; http://dx.doi.org/10.1016/j.jiph. 2011.11.003
28. Celikbas A, Ergonul O, Aksaray S, Tuygun N, Esener H, Tanir G, Eren S, Baykam N, Guvener E, Dokuzoguz B. Measles, rubella, mumps, and varicella seroprevalence among health care workers in Turkey: is prevaccination screening cost-effective? Am J Infect Control 2006; 34:583-7; PMID:17097453; http://dx.doi.org/10.1016/j.ajic.2006.04.213
29. Barrabeig I, Torner N, Martínez A, Carmona G, Ciruela P, Batalla J, Costa J, Hernández S, Salleras L, Domínguez A. Group Of Catalonia TR Results of the rubella elimination program in Catalonia (Spain), 2002-2011. Hum Vaccin Immunother 2013; 9: (Forthcoming); http://dx.doi.org/10. 4161/hv.23260
30. Dinelli MI, Moreira Td, Paulino ER, da Rocha MC, Graciani FB, de Moraes-Pinto MI. Immune status and risk perception of acquisition of vaccine preventable diseases among health care workers. Am J Infect Control 2009; 37:858-60; PMID:19608297; http://dx.doi.org/10.1016/j.ajic.2009.04.283
31. Singh MP, Diddi K, Dogra S, Suri V, Varma S, Ratho RK. Institutional outbreak of rubella in a healthcare center in Chandigarh, North India. J Med Virol 2010; 82:341-4; PMID:20029806; http://dx.doi.org/10.1002/jmv.21672
32. Hinman AR, Irons B, Lewis M, Kandola K. Economic analyses of rubella and rubella vaccines: a global review. Bull World Health Organ 2002; 80:264-70; PMID:12075361
33. Santos-Sancho JM, Gil-Prieto R, Álvaro-Meca A, Gil-de Miguel A. Epidemiología de las hospitalizaciones causadas por rubéola en la población general en España (1997-2006). An Sist Sanit Navar 2010; 33:65-70; PMID:20463772; http://dx.doi.org/10.4321/S1137-66272010000100007
34. Lindley MC, Horlick GA, Shefer AM, Shaw FE, Gorji M. Assessing state immunization requirements for healthcare workers and patients. Am J Prev Med 2007; 32:459-65; PMID:17533060; http://dx.doi.org/10.1016/j.amepre.2007.02.009
35. Helms C, Leask J, Robbins SC, Chow MY, McIntyre P. Implementation of mandatory immunisation of healthcare workers: observations from New South Wales, Australia. Vaccine 2011; 29:2895-901; PMID:21338677; http://dx.doi.org/10.1016/ j.vaccine.2011.02.011